Sacramento, CA, United States of America

Edward Yat Tom


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 81(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Edward Yat Tom: Innovator in Cancer Research

Introduction

Edward Yat Tom is a notable inventor based in Sacramento, CA. He has made significant contributions to the field of cancer research through his innovative work on p53-regulated genes. His research has implications for understanding cancer mechanisms and developing therapeutic strategies.

Latest Patents

Edward Yat Tom holds a patent related to p53-regulated genes. This patent identifies many genes that are regulated by p53, which were previously unknown. The genes include those whose expression is either induced or repressed by wild-type p53. Monitoring the expression of these genes provides valuable insights into p53 status in cells. This monitoring can also be utilized to screen for effective anti-cancer therapeutics and identify carcinogenic substances. Furthermore, defects in p53 can be circumvented by supplying p53-induced genes or antisense constructs to p53-repressed genes. He has 1 patent in this area.

Career Highlights

Throughout his career, Edward Yat Tom has worked with prominent organizations, including Affymetrix, Inc. and Princeton University. His work has been instrumental in advancing the understanding of cancer biology and therapeutic development.

Collaborations

Edward has collaborated with esteemed colleagues such as Arnold J. Levine and Maureen Elizabeth Murphy. Their joint efforts have contributed to significant advancements in cancer research.

Conclusion

Edward Yat Tom's innovative work on p53-regulated genes has made a lasting impact on cancer research. His contributions continue to influence the development of new therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…